CCEL Stock - Cryo-Cell International, Inc.
Unlock GoAI Insights for CCEL
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $31.99M | $31.34M | $30.34M | $28.88M | $31.15M |
| Gross Profit | $24.04M | $22.90M | $21.54M | $19.90M | $21.49M |
| Gross Margin | 75.2% | 73.1% | 71.0% | 68.9% | 69.0% |
| Operating Income | $3.48M | $-12,304,032 | $4.02M | $4.02M | $7.66M |
| Net Income | $402,095 | $-9,521,669 | $2.77M | $2.08M | $3.62M |
| Net Margin | 1.3% | -30.4% | 9.1% | 7.2% | 11.6% |
| EPS | $0.05 | $-1.14 | $0.33 | $0.26 | $0.48 |
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Visit WebsiteEarnings History & Surprises
CCELEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 27, 2026 | — | — | — | — |
Q4 2025 | Oct 15, 2025 | — | $0.09 | — | — |
Q3 2025 | Jul 15, 2025 | $-0.03 | $0.04 | +233.3% | ✓ BEAT |
Q1 2025 | Feb 28, 2025 | $0.01 | $-0.23 | -2400.0% | ✗ MISS |
Q1 2025 | Feb 26, 2025 | $0.01 | $0.26 | +2500.0% | ✓ BEAT |
Q4 2024 | Oct 15, 2024 | $0.02 | $0.13 | +550.0% | ✓ BEAT |
Q3 2024 | Jul 15, 2024 | $0.04 | $0.08 | +100.0% | ✓ BEAT |
Q2 2024 | Apr 15, 2024 | $-0.00 | $0.07 | +1815.7% | ✓ BEAT |
Q1 2024 | Feb 28, 2024 | $-0.07 | $0.26 | +471.4% | ✓ BEAT |
Q4 2023 | Oct 12, 2023 | $-0.06 | $0.08 | +233.3% | ✓ BEAT |
Q3 2023 | Jul 14, 2023 | $-0.08 | $0.03 | +137.5% | ✓ BEAT |
Q2 2023 | Apr 21, 2023 | $0.02 | $0.09 | +324.9% | ✓ BEAT |
Q1 2023 | Feb 28, 2023 | $0.01 | $0.10 | +599.8% | ✓ BEAT |
Q4 2022 | Oct 14, 2022 | — | $0.06 | — | — |
Q3 2022 | Jul 11, 2022 | — | $0.07 | — | — |
Q2 2022 | Apr 13, 2022 | — | $0.10 | — | — |
Q1 2022 | Feb 22, 2022 | — | $-0.08 | — | — |
Q4 2021 | Oct 15, 2021 | — | $0.10 | — | — |
Q3 2021 | Jul 15, 2021 | — | $0.14 | — | — |
Q2 2021 | Apr 14, 2021 | — | $0.08 | — | — |
Latest News
Frequently Asked Questions about CCEL
What is CCEL's current stock price?
What is the analyst price target for CCEL?
What sector is Cryo-Cell International, Inc. in?
What is CCEL's market cap?
Does CCEL pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to CCEL for comparison